Comparison 11. Serious adverse events: immune thrombocytopenic purpura ‐ cohort studies.
Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
---|---|---|---|---|
1 Seasonal influenza vaccine ‐ HR (adjusted data) | 1 | Hazard Ratio (Random, 95% CI) | Subtotals only | |
1.1 General population | 0 | Hazard Ratio (Random, 95% CI) | 0.0 [0.0, 0.0] | |
1.2 Pregnant women | 1 | Hazard Ratio (Random, 95% CI) | 0.90 [0.68, 1.19] | |
2 Seasonal influenza vaccine (unadjusted data) | 1 | Odds Ratio (M‐H, Random, 95% CI) | Subtotals only | |
2.1 General population | 0 | 0 | Odds Ratio (M‐H, Random, 95% CI) | 0.0 [0.0, 0.0] |
2.2 Pregnant women | 1 | 223898 | Odds Ratio (M‐H, Random, 95% CI) | 0.92 [0.70, 1.20] |